AI science tools speed up drug discovery with data-driven retargeting
Two new AI systems demonstrate how automation can accelerate early-stage drug development by scanning vast datasets to identify potential repurposing candidates. These tools integrate with existing lab workflows without replacing human expertise, setting a new benchmark for computational biology.